Syngene International Intrinsic Value
Syngene International intrinsic value. Syngene International (SYNGENE) median intrinsic value is ₹131.21 from 9 valuation models (range ₹131–₹276), vs current price ₹437.35 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Browse Syngene International annual reports for revenue, profit, balance sheet and cash flow data.
SYNGENE Valuation Methods Summary — DCF, Graham Number & P/E
Syngene International intrinsic value across 9 models vs current price ₹437.35 — upside/downside and value range per method. Analyse SYNGENE shareholding pattern to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹131.21 | ₹104.97 - ₹157.45 | -70.0% | EPS: ₹3.20, Sector P/E: 22x |
| Book Value Method | asset | ₹240.15 | ₹216.14 - ₹264.17 | -45.1% | Book Value/Share: ₹120.07, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹170.92 | ₹153.83 - ₹188.01 | -60.9% | Revenue/Share: ₹85.46, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹174.94 | ₹157.45 - ₹192.43 | -60.0% | EBITDA: ₹676.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹275.95 | ₹220.76 - ₹331.14 | -36.9% | CF Growth: 12.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹131.21 | ₹118.09 - ₹144.33 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹131.21 | ₹118.09 - ₹144.33 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| Graham Defensive Method | conservative | ₹131.21 | ₹118.09 - ₹144.33 | -70.0% | EPS: ₹3.20, BVPS: ₹120.07 |
| Dividend Yield Method | dividend | ₹131.21 | ₹118.09 - ₹144.33 | -70.0% | DPS: ₹1.25, Target Yield: 2.5% |
SYNGENE Intrinsic Value vs Market Price — All Valuation Models
Syngene International fair value range ₹131–₹276 vs current market price ₹437.35 across 9 valuation models. For current market price and key ratios, visit SYNGENE share price.
SYNGENE Intrinsic Value Analysis — Undervalued or Overvalued?
Syngene International median intrinsic value ₹131.21, current price ₹437.35 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.
What is the intrinsic value of SYNGENE?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Syngene International (SYNGENE) is ₹131.21 (median value). With the current market price of ₹437.35, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹131.21 to ₹275.95, indicating ₹131.21 - ₹275.95.
Is SYNGENE undervalued or overvalued?
Based on our multi-method analysis, Syngene International (SYNGENE) appears to be trading above calculated value by approximately 70.0%.
SYNGENE Financial Health — Key Ratios vs Industry Benchmarks
Syngene International financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 2.6% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 17.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.49x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
SYNGENE Cash Flow Quality — Operating & Free Cash Flow
Syngene International operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹915 Cr | ₹496 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹1,168 Cr | ₹796 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹1,042 Cr | ₹795 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹824 Cr | ₹498 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹581 Cr | ₹276 Cr | Positive Free Cash Flow | 7/10 |